NASDAQ:FLXN - Flexion Therapeutics, Inc.
$10.56
 $-0.29
-2.67%
4:00PM EDT
2019-07-22
Flexion Therapeutics, Inc. is a United States-based specialty pharmaceutical company. The Company is focused on the development and commercialization of local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. The Company's lead product candidate, Zilretta, is a late-stage, injectable, extended-release, intra-articular (IA) investigational steroid. The Company is developing Zilretta as a treatment for patients with moderate to severe OA knee pain. The Company has specifically designed Zilretta to combine a steroid, triamcinolone acetonide (TCA) with poly lactic-co-glycolic acid (PLGA), for providing sustained therapeutic concentrations in the joint and persistent analgesic effect. The Company's other product candidates include FX007 for post-operative pain and FX005 for the treatment of end-stage OA patients. The Company is engaged in conducting a Phase IIb clinical trial of Zilretta. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  FLXN     avg for
industry  
  avg for
sector  
42 stocks weight:  30. 34   217. 37   399. 45  
42 stocks rank:  2. 86 K 1. 27 K 716. 99  
# analyst opinions:  9. 00   13. 21   13. 71  
mean recommendation:  1. 80   2. 10   2. 04  

quick ratio:  5. 96   5. 49   1. 88  
current ratio:  6. 32   5. 87   2. 36  

target price low:  19. 00   83. 44   114. 90  
target price avg:  26. 44   106. 20   137. 90  
target price high:  11. 46   132. 30   158. 97  
1-yr high:  27. 22   111. 86   142. 57  
last close:  10. 85   86. 79   125. 44  
50-day avg:  11. 65   86. 68   122. 63  
200-day avg:  13. 34   89. 22   121. 38  
1-yr low:  9. 68   69. 78   100. 51  
volume:  307. 96 K 2. 62 M 3. 43 M
50-day avg volume:  552. 35 K 3. 20 M 4. 16 M
200-day avg volume:  648. 52 K 2. 99 M 4. 75 M

1-day return:  -0. 64 % -1. 30 % -0. 99 %
this week return:  0. 56 % 0. 45 % -0. 20 %
12-wk return:  -1. 63 % 0. 94 % 4. 84 %
52-wk return:  -59. 88 % -1. 30 % 10. 55 %

enterprise value (EV):  359. 08 M 45. 10 B 122. 38 B
market cap:  412. 22 M 38. 96 B 108. 40 B
EBITDA:  -157. 72 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -2. 28   5. 38   11. 93  
enterprise/revenue (EV/R):  11. 62   57. 92   10. 21  
total revenue:  30. 89 M 9. 91 B 39. 98 B
total debt:  165. 00 M 10. 90 B 17. 48 B
debt/equity:  227. 35   57. 18   120. 05  
net income (common):  -169. 63 M 2. 07 B 4. 05 B

shares outstanding:  37. 99 M 538. 09 M 1. 24 B
shares:  33. 23 M 548. 00 M 1. 22 B
shares short:  7. 92 M 10. 98 M 11. 87 M
shares short prior month:  7. 54 M 9. 32 M 12. 05 M
short ratio:  15. 46   5. 60   3. 34  
short % of float:  26. 95 % 6. 48 % 2. 64 %
total cash/share:  5. 74   10. 98   9. 19  
total cash:  218. 14 M 5. 93 B 6. 10 B
free cash flow:  -94. 20 M 2. 92 B 4. 55 B
operating cash flow:  -153. 42 M 3. 80 B 5. 78 B

book value:  1. 91   13. 35   27. 45  
price/book:  5. 68   4. 60   8. 78  
gross profits:  15. 19 M 7. 44 B 36. 13 B
operating margins:  -514. 96 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  79. 43 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -4. 48   2. 10   4. 23  
forward EPS:  -2. 25   3. 45   7. 10  
P/E:  -2. 42   1. 90   32. 10  
forward P/E:  -4. 82   6. 46   15. 47  
PE/G:  -0. 01   0. 70   -0. 54  
growth:  381. 50 % 265. 63 % 79. 11 %
earnings high:  -1. -1   0. 89   1. 68  
earnings avg:  -1. 05   0. 70   1. 57  
earnings low:  -1. 13   0. 46   1. 46  
revenue high:  16. 00 M 2. 57 B 11. 07 B
revenue avg:  14. 70 M 2. 51 B 10. 91 B
revenue low:  12. 60 M 2. 45 B 10. 73 B
return on assets:  -30. 05 % -2. 34 % 5. 28 %
return on equity:  -114. 93 % -90. 08 % 133. 53 %
revenue growth:  381. 50 % 265. 25 % 73. 68 %
revenue/share:  0. 82   12. 72   60. 04  

beta (1yr vs S&P500):  1. 41   1. 27   0. 91  
sharpe (1yr):  -1. 19   0. 16   0. 77  

held % insiders:  1. 98 % 6. 06 % 3. 29 %
held % institutions:  115. 18 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : FLXN
.    113.595 =       113.595 :: --> INITIAL WEIGHT <--
.    - 4.482 =       109.113 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.029 =       221.383 :: P/E factor
.    x 2.209 =       489.027 :: PE/G factor
.     x 1.48 =       723.922 :: beta factor
.    x 0.892 =        645.87 :: sharpe factor
.    x 2.922 =      1887.528 :: current ratio factor
.    x 1.096 =      2069.002 :: quick ratio factor
.    x 1.032 =      2134.869 :: short ratio factor
.    x 3.069 =      6551.185 :: revenue growth factor
.    x 1.201 =      7865.737 :: EV/R factor
.    x 1.069 =      8411.979 :: price-to-book factor
.    x 0.705 =      5927.566 :: debt-to-revenue factor
.    x 1.725 =     10225.457 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     21686.077 :: sector+industry 1-year gains factor
.    x 1.009 =     21890.535 :: industry 12-weeks return factor
.    x 1.308 =      28630.38 :: industry 2-weeks return factor
.    x 0.865 =     24777.697 :: company one-year gains+dividend factor
.    x 2.176 =     53919.168 :: company 13 weeks' performance factor
.    x 0.987 =     53236.861 :: "drift" penalty 1 days ago
.    x 0.973 =      51814.88 :: "drift" penalty 2 days ago
.    / 2.023 =       25616.0 :: overall "drift" factor
.    x 0.899 =      23030.47 :: largest single-day jump factor
.    x 0.158 =      3638.305 :: low price factor
.    x 1.263 =      4593.771 :: notable returns + performance factor
.    x 3.502 =     16089.652 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.772 =     12429.208 :: forward EPS factor
.    x 0.917 =     11401.685 :: forward P/E factor
.    x 1.185 =     13507.718 :: industry recommendation factor
.    x 2.554 =     34497.746 :: company recommendation factor
.    x 1.003 =     34593.145 :: factor historical industry gain for week 29
.   x 10.916 =    377620.358 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        24.789 :: reduced for readability
.    + 5.554 =        30.343 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     30.343 :: FINAL WEIGHT for NASDAQ:FLXN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org